References
Hanaki C, Fujii K, Morio M, Tashima T (1989) Decomposition of sevoflurane by sodalime. Hiroshima J Med Sci 36:61–67
Morio M, Fujii K, Satoh N, Imai M, Kawakami U, Mizuno T, Kawai Y, Ogasawara Y, Tamura T, Negishi A, Kumag R, Kawai T (1992) Reaction of sevoflurane and its degradation products with soda lime. Anesthesiology 77:1155–1164
Gonsowski CT, Laster MJ, Roger EI, Eger II EI, Ferrell LD, Kerschmann RL (1994) Toxicity of compound A in rats. Anesthesiology 80:556–565
Kenna JG, Jones RM (1995) The organ toxicity of inhaled anesthetics. Anesth Analg 81:S51-S66
Frink EJ, Malan TP, Morgan SE, Brown EA, Malcomson M, Brown BR Jr (1992) Quantification of degradation products of sevoflurane in two CO2 absorbents during low-flow anesthesia in surgical patients. Anesthesiology 77:1064–1069
Bito H, Ikeda K (1994) Closed-circuit anesthesia with sevoflurane in humans: Effect on renal and hepatic function, and concentrations of breakdown products with sodalime in the circuit. Anesthesiology 80:71–76
Jin L, Bailic TA, Davis MR, Kharasch ED (1995) Nephrotoxicity of sevoflurane compound A in rats: Evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate β-lyase. Biochem Biophys Res Commun 210:498–506
Martin JL, Laster MJ, Kandel L, Kerschmann RL, Reed GF, Eger II EI (1996) Metabolism of compound A by renal cysteine-S-conjugate β-lyase is not the mechanism of compound A-induced renal injury in rats. Anesth Analg 82:770–774
Martin JL, Kandel L, Laster M, Kerschmann RL, Eger II EI (1996) Studies of the mechanism of the nephrotoxicity of compound A in rats. J Anesth 11:32–37
Roizen MF (1996) In response to letters to the editor. Anesth Analg 82:432–433
Author information
Authors and Affiliations
About this article
Cite this article
Yuge, O. Renal toxicity of compound A with sevoflurane anesthesia: The benefits of sevoflurane appear to outweigh the risks. J Anesth 11, 1–2 (1997). https://doi.org/10.1007/BF02479995
Issue Date:
DOI: https://doi.org/10.1007/BF02479995